Enteris has the expertise to provide end-to-end analytical support including analytical method development and validation.
Our analytical team has extensive knowledge of current and evolving FDA and ICH guidelines, and apply a risk-based, phase-appropriate approach to cGMP analytical activities along with industry leading analytical method development and analytical validation.
We provide analytical support to our clients for all stages of drug development, from early characterization of drug substance and solubility screening to stability studies and process validation.
